Ischemia Reperfusion Injury Therapeutics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Ischemia Reperfusion Injury Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Ischemia Reperfusion Injury Therapeutics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
ANV-6L15
APP-103
BAY-606583
EP-80317
GS-459679
KN-93
LH-021
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Nyken B.V.
Omeros Corporation
Opsona Therapeutics Limited
Orexo AB
Pharming Group N.V.
PledPharma AB
Prolong Pharmaceuticals
Proteo, Inc.
Prothix BV
Stealth BioTherapeutics Inc.
Zealand Pharma A/S
Amyndas Pharmaceuticals LLC
Angion Biomedica Corp.
Antipodean Pharmaceuticals, Inc.
Bayer AG
Biomedica Management Corporation
Bolder Biotechnology, Inc.
Curatis Pharma GmbH
Ensemble Therapeutics Corporation
Erimos Pharmaceuticals, LLC
Gilead Sciences, Inc.